• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碱性磷酸酶持续升高作为GM1神经节苷脂贮积症的早期指标。

Persistent elevations of alkaline phosphatase as an early indicator of GM1 gangliosidosis.

作者信息

Menkovic Iskren, Williams Monika, Makhijani Neelam, Wei Ruhan, Young Sarah P, El-Gharbawy Areeg, Stiles Ashlee R

机构信息

Biochemical Genetics Laboratory, Duke University Health System, Durham, NC, USA.

Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.

出版信息

Mol Genet Metab Rep. 2025 Jan 20;42:101191. doi: 10.1016/j.ymgmr.2025.101191. eCollection 2025 Mar.

DOI:10.1016/j.ymgmr.2025.101191
PMID:39897471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11786200/
Abstract

-related disorders are autosomal recessive lysosomal diseases caused by enzymatic deficiency of β-galactosidase. Enzymatic deficiency of β-galactosidase may lead to one of two phenotypes, GM1 gangliosidosis or mucopolysaccharidosis IVB (MPS IVB). GM1 gangliosidosis is a neurodegenerative disorder with variable skeletal disease and involvement of other systems. The age of onset correlates with the extent of neurological involvement and established genotype/phenotype correlations. Mucopolysaccharidosis IVB is characterized by a skeletal dysplasia without neurological involvement. Diagnostic work-up for related disorders includes enzyme analysis, biomarker analysis, molecular testing, and laboratory imaging studies. We report a patient who presented with persistent elevations of alkaline phosphatase (ALP) and subtle dysmorphic facial features. An initial skeletal survey at birth was unrevealing; however, a repeat at 3 months of age was abnormal with anterior beaking of the lumbar vertebrae and hemivertebrae of the lower cervical spine. Urinary glycosaminoglycan (GAG) analysis revealed a marked elevation of keratan sulfate (KS). Clinical exome sequencing revealed pathogenic heterozygous variants in , consistent with -related GM1 gangliosidosis. Our case demonstrates that persistent elevations of ALP may be an early indicator for GM1 gangliosidosis in an infant with progressive multisystem disease, indicating the need for early genetic consultation. This case also highlights the utility of repeat skeletal surveys with abnormalities detected at 3 months of age.

摘要

相关疾病是由β-半乳糖苷酶酶缺乏引起的常染色体隐性溶酶体疾病。β-半乳糖苷酶酶缺乏可能导致两种表型之一,即GM1神经节苷脂贮积症或IVB型黏多糖贮积症(MPS IVB)。GM1神经节苷脂贮积症是一种神经退行性疾病,伴有可变的骨骼疾病和其他系统受累。发病年龄与神经受累程度以及已确定的基因型/表型相关性有关。IVB型黏多糖贮积症的特征是骨骼发育异常但无神经受累。相关疾病的诊断检查包括酶分析、生物标志物分析、分子检测和实验室影像学研究。我们报告了一名患者,其碱性磷酸酶(ALP)持续升高且面部有细微畸形特征。出生时的首次骨骼检查未发现异常;然而,3个月大时复查异常,腰椎椎体前缘呈喙状,下颈椎半椎体畸形。尿糖胺聚糖(GAG)分析显示硫酸角质素(KS)显著升高。临床外显子组测序显示致病杂合变异,与相关的GM1神经节苷脂贮积症一致。我们的病例表明,对于患有进行性多系统疾病的婴儿,ALP持续升高可能是GM1神经节苷脂贮积症的早期指标,这表明需要早期进行遗传咨询。该病例还强调了3个月大时检测到异常后重复进行骨骼检查的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/11786200/fb20a01ef19d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/11786200/fb20a01ef19d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/375e/11786200/fb20a01ef19d/gr1.jpg

相似文献

1
Persistent elevations of alkaline phosphatase as an early indicator of GM1 gangliosidosis.碱性磷酸酶持续升高作为GM1神经节苷脂贮积症的早期指标。
Mol Genet Metab Rep. 2025 Jan 20;42:101191. doi: 10.1016/j.ymgmr.2025.101191. eCollection 2025 Mar.
2
Characterization of glycan substrates accumulating in GM1 Gangliosidosis.GM1神经节苷脂贮积症中积累的聚糖底物的表征
Mol Genet Metab Rep. 2019 Nov 3;21:100524. doi: 10.1016/j.ymgmr.2019.100524. eCollection 2019 Dec.
3
Diagnostic challenge for the rare lysosomal storage disease: Late infantile GM1 gangliosidosis.罕见溶酶体贮积病的诊断挑战:晚发性婴儿型GM1神经节苷脂病。
Brain Dev. 2018 May;40(5):383-390. doi: 10.1016/j.braindev.2018.01.009. Epub 2018 Feb 10.
4
Protein modeling and clinical description of a novel in-frame GLB1 deletion causing GM1 gangliosidosis type II.一种导致II型GM1神经节苷脂贮积症的新型框内GLB1缺失的蛋白质建模与临床描述
Mol Genet Genomic Med. 2018 Nov;6(6):1229-1235. doi: 10.1002/mgg3.454. Epub 2018 Sep 5.
5
Case reports of juvenile GM1 gangliosidosisis type II caused by mutation in GLB1 gene.由GLB1基因突变引起的青少年II型GM1神经节苷脂贮积症的病例报告。
BMC Med Genet. 2017 Jul 17;18(1):73. doi: 10.1186/s12881-017-0417-4.
6
[Genetic and clinical analysis of a novel GLB1 gene variant in a Chinese patient with GM1-gangliosidosis].[一名中国GM1神经节苷脂贮积症患者中新型GLB1基因突变的遗传与临床分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2022 May 10;39(5):537-541.
7
GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings.GM1神经节苷脂贮积症和莫尔基奥B病:基因改变与临床发现的最新进展
Biochim Biophys Acta. 2011 Jul;1812(7):782-90. doi: 10.1016/j.bbadis.2011.03.018. Epub 2011 Apr 7.
8
Case report: Preimplantation genetic testing for infantile GM1 gangliosidosis.病例报告:婴儿型GM1神经节苷脂贮积症的植入前基因检测
Front Genet. 2024 Feb 9;15:1344051. doi: 10.3389/fgene.2024.1344051. eCollection 2024.
9
The skeletal phenotype of intermediate GM1 gangliosidosis: Clinical, radiographic and densitometric features, and implications for clinical monitoring and intervention.中间型 GM1 神经节苷脂贮积症的骨骼表型:临床、影像学和骨密度特征及其对临床监测和干预的影响。
Bone. 2020 Feb;131:115142. doi: 10.1016/j.bone.2019.115142. Epub 2019 Nov 6.
10
Human knockout cerebral organoids: A model system for testing AAV9-mediated gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosis.人类基因敲除脑类器官:一种用于测试AAV9介导的基因疗法以减少GM1神经节苷脂病中GM1神经节苷脂蓄积的模型系统。
Mol Genet Metab Rep. 2019 Sep 11;21:100513. doi: 10.1016/j.ymgmr.2019.100513. eCollection 2019 Dec.

引用本文的文献

1
The Critical Role of Vitamin D Supplementation for Skeletal and Neurodevelopmental Outcomes in Preterm Neonates.补充维生素D对早产儿骨骼和神经发育结局的关键作用
Nutrients. 2025 Apr 19;17(8):1381. doi: 10.3390/nu17081381.

本文引用的文献

1
GM1 gangliosidosis type II: Results of a 10-year prospective study.GM1 神经节苷脂贮积症 II 型:一项 10 年前瞻性研究的结果。
Genet Med. 2024 Jul;26(7):101144. doi: 10.1016/j.gim.2024.101144. Epub 2024 Apr 16.
2
Benign transient hyperphosphatasemia in infants and children: a retrospective database study.婴儿和儿童良性一过性高磷酸酶血症:一项回顾性数据库研究。
Eur J Pediatr. 2023 Jul;182(7):3211-3216. doi: 10.1007/s00431-023-04995-1. Epub 2023 May 2.
3
GM1 gangliosidosis: patients with different phenotypic features and novel mutations.
GM1 神经节苷脂贮积症:具有不同表型特征和新突变的患者。
J Pediatr Endocrinol Metab. 2023 Apr 13;36(6):602-607. doi: 10.1515/jpem-2022-0630. Print 2023 Jun 27.
4
Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry.采用同位素稀释液相色谱-电喷雾串联质谱法定量尿液中的糖胺聚糖。
Curr Protoc. 2023 Mar;3(3):e701. doi: 10.1002/cpz1.701.
5
GM1-gangliosidosis: The caregivers' assessments of symptom impact and most important symptoms to treat.GM1 神经节苷脂贮积症:照料者对症状影响的评估以及最需要治疗的症状。
Am J Med Genet A. 2023 Feb;191(2):408-423. doi: 10.1002/ajmg.a.63038. Epub 2022 Dec 21.
6
Late-infantile GM1 gangliosidosis: A case report.晚期婴儿型GM1神经节苷脂贮积症:一例报告。
Medicine (Baltimore). 2022 Jan 7;101(1):e28435. doi: 10.1097/MD.0000000000028435.
7
GM1 Gangliosidosis-A Mini-Review.GM1神经节苷脂贮积症——一篇小型综述。
Front Genet. 2021 Sep 3;12:734878. doi: 10.3389/fgene.2021.734878. eCollection 2021.
8
Are GMI gangliosidosis and Morquio type B two different disorders or part of one phenotypic spectrum?GMI神经节苷脂贮积症和B型黏多糖贮积症Ⅱ型是两种不同的疾病,还是同一表型谱的一部分?
JIMD Rep. 2021 Mar 18;59(1):90-103. doi: 10.1002/jmd2.12204. eCollection 2021 May.
9
GM1 Gangliosidosis: Mechanisms and Management.GM1神经节苷脂贮积症:发病机制与治疗
Appl Clin Genet. 2021 Apr 9;14:209-233. doi: 10.2147/TACG.S206076. eCollection 2021.
10
Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience.米格列醇治疗 GM1 型神经节苷脂贮积症患儿的底物还原疗法可延迟神经受累:一项多中心经验。
Mol Genet Genomic Med. 2020 Oct;8(10):e1371. doi: 10.1002/mgg3.1371. Epub 2020 Aug 11.